To show that EGFR ligands do not affect the phosphorylation of ErbB3, we investigated the phosphorylation of EGFR and ErbB3 in cancer cell lines treated with EGF, transforming growth factor-α (TGF-α), or heparin-binding EGF-like growth factor (HB-EGF). Here, ERBB3 is linked to cancer.